Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss ...

LBC can reveal the Advertising Standards Authority issued a warning to a weight loss treatment provider over an advert which ...

While an ad for Ozempic or Mounjaro on TV may have a strong free speech defense, marketing or sales efforts directed toward doctors may be an easier target. "I don't think the First Amendment ...

In a year when GLP-1 drugs were a best-selling, buzzy phenomenon, Novo Nordisk’s ad spend for Ozempic in streaming TV has been paying off. The brand’s ads were 57% more effective in driving ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...

American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

The FDA's move may change how doctors treat chronic kidney disease, which, according to Ozempic maker Novo Nordisk, affects around 37 million Americans and is one of the leading causes of death in the ...

While an ad for Ozempic or Mounjaro on TV may have a strong free speech defense, marketing or sales efforts directed toward doctors may be an easier target. “I don’t think the First Amendment ...